ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 660 filers reported holding ASTRAZENECA PLC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,223,640 | +94.7% | 18,070 | +105.8% | 0.24% | +62.4% |
| Q2 2023 | $628,549 | +3.9% | 8,782 | +0.8% | 0.15% | -2.6% |
| Q1 2023 | $604,859 | -1.2% | 8,714 | -3.5% | 0.15% | -0.6% |
| Q4 2022 | $612,299 | +14.7% | 9,031 | -7.3% | 0.15% | +8.5% |
| Q3 2022 | $534,000 | -19.3% | 9,746 | -2.7% | 0.14% | -17.0% |
| Q2 2022 | $662,000 | +2.5% | 10,017 | +2.9% | 0.17% | +15.5% |
| Q1 2022 | $646,000 | +19.9% | 9,737 | +8.4% | 0.15% | +0.7% |
| Q3 2021 | $539,000 | +41.8% | 8,982 | +41.7% | 0.15% | +47.0% |
| Q2 2021 | $380,000 | +29.7% | 6,338 | +7.4% | 0.10% | +163.2% |
| Q1 2021 | $293,000 | 0.0% | 5,902 | +0.8% | 0.04% | -57.8% |
| Q4 2020 | $293,000 | -8.7% | 5,855 | 0.0% | 0.09% | -20.4% |
| Q3 2020 | $321,000 | -11.8% | 5,855 | -28.1% | 0.11% | -26.1% |
| Q1 2020 | $364,000 | -10.3% | 8,147 | 0.0% | 0.15% | +70.0% |
| Q4 2019 | $406,000 | +11.8% | 8,147 | 0.0% | 0.09% | -1.1% |
| Q3 2019 | $363,000 | +8.4% | 8,147 | +0.4% | 0.09% | -50.8% |
| Q2 2019 | $335,000 | – | 8,111 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |